Close
A UCL-TB event to discuss TB treatment access challenges across different settings
Wednesday 12th June, 15:00-16:00 BST
Despite the development of new drugs, and trials to support more effective treatment regimens for TB, cure cannot be achieved without access to medicines. Drug pricing, access policies and patent issues are often responsible for inequalities in getting access to lifesaving medicines to people that need most. Our previous webinar gave an overview of these issues. In our next webinar in this series we will explore, in-depth, access to Rifapentine. Two talks from experts in the field will cover the evidence behind rifapentine's use in TB and unpack specific barriers to its use. This will be followed by discussions with the audience.
This event can be viewed on YouTube here
00:03 Introduction to the event by Jess Potter
02:40 Comments from Christoph Lange (Medical Director, Research Center Borstel, Germany; read by Jess Potter)
04:06 Gabriella Ferlazzo (TB Medical Adviser MSF Access Campaign)
4:51 Introduction for next section
35:38 Isabel Carvalho, National TB Programme, Portugal
41:29 Judith Bruchfeld, Karolinska Institutet, Sweden
46:19 Questions and discussion
Organizers: Ilaria Motta and Jess Potter
Speakers:
Gabriella Ferlazzo
TB Medical Adviser MSF Access Campaign
Gabriella is an infectious disease physician. She works as TB medical adviser at Medecins sans Frontières (MSF) Access Campaign and as independent consultant and for other international organizations. She started her professional engagement in humanitarian settings in 2008, working initially as field clinician in the context of different migration, TB/HIV and Ebola projects, then as TB/HIV technical and strategic adviser for MSF in several African, Asian and EECA countries. Gabriella's current research and advocacy activities, focusing on new TB/DRTB treatment and TB diagnostic and prevention strategies, aim at improving provision of TB/DRTB care for the most vulnerable populations, including children.
Christoph Lange
Medical Director, Research Center Borstel, Germany
Christoph is a physician scientist with a strong interest in European healthcare systems and personalized medicine for patients with tuberculosis, especially drug-resistant cases. In 2014 he was appointed as Medical Director of the Clinical Infectious Diseases at the Medical Clinic of the Research Center Borstel, Leibniz Lung Center. He is also member of Steering Committee for TBnet, where he is responsible for Education.
Note that details may change. The workshop will be recorded and made available online at the UCL-TB YouTube site after the event.